Fulgent Genetics FLGT
$24.12 −$0.66 (-2.66%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $24.12 0.00%
Open$24.50
Prev close$24.78
Day range$23.88 – $24.79
Volume323.0K
Market cap$673.89M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$90.41M+7.5% YoY
Operating profit-$22.55M-46.9% YoY
Net profit-$13.34M-95.4% YoY
Diluted EPS-$0.48-128.6% YoY
Free cash flow$107.44M+2,024.7% YoY
Operating cash flow$109.23M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin33.8%
Operating margin-38.5%
Net margin-27.5%
Return on equity-8.6%
Return on assets-7.9%
Return on invested capital-11.2%
Current ratio5.34
Liabilities / assets8.7%
Cash & investments$292.74M
Total debt$8.17M
Net cash (debt)$284.57M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $90.41M | $85.39M | $71.14M | $322.67M | $83.34M |
| Total Operating Revenue | $90.41M | $85.39M | $71.14M | $322.67M | $83.34M |
| Cost of Revenue | $58.47M | $59.71M | $49.65M | $191.80M | $50.75M |
| Gross Profit | $31.95M | $25.68M | $21.49M | $130.88M | $32.58M |
| Operating Expense | $54.49M | $59.58M | $56.11M | $221.97M | $68.82M |
| Selling and Admin Expenses | $38.37M | $42.42M | $39.91M | $160.04M | $52.62M |
| -Selling & Marketing Expense | $15.61M | $15.23M | $12.22M | $43.37M | $10.98M |
| -General & Admin Expense | $22.76M | $27.20M | $27.68M | $116.66M | $41.65M |
| Research & Development | $13.64M | $14.55M | $14.18M | $53.91M | $14.17M |
| Depreciation & Amortization & Depletion | $2.49M | $2.60M | $2.03M | $8.03M | $2.03M |
| -Depreciation & Amortization | $2.49M | $2.60M | $2.03M | $8.03M | $2.03M |
| Operating Profit | -$22.55M | -$33.90M | -$34.62M | -$91.10M | -$36.24M |
| Net Non-Operating Interest Income (Expense) | $8.55M | $6.35M | $8.63M | $30.84M | $6.92M |
| Non-Operating Interest Income | $8.55M | $6.40M | $8.65M | $30.92M | $6.94M |
| Non-Operating Interest Expense | $7,000.00 | $59,000.00 | $17,000.00 | $75,000.00 | $16,000.00 |
| Other Income (Expense) | -$43,000.00 | -$2.13M | $10,000.00 | -$9.77M | $44,000.00 |
| Special Income (Charges) | $0.00 | -$2.17M | – | -$9.93M | $0.00 |
| -Less:Impairment of Capital Assets | $0.00 | $2.17M | – | $0.00 | $0.00 |
| -Less:Write Off | $0.00 | $0.00 | – | $9.93M | $0.00 |
| Other Non-Operating Income (Expenses) | -$43,000.00 | $38,000.00 | $10,000.00 | $153,000.00 | $44,000.00 |
| Pretax Profit | -$14.04M | -$29.69M | -$25.98M | -$70.03M | -$29.27M |
| Tax | -$704,000.00 | $29,000.00 | -$704,000.00 | -$8.39M | -$5.62M |
| Net Profit | -$13.34M | -$29.72M | -$25.27M | -$61.63M | -$23.65M |
| Profit from Continuing Operations | -$13.34M | -$29.72M | -$25.27M | -$61.63M | -$23.65M |
| Minority Interests | -$187,000.00 | -$189,000.00 | -$448,000.00 | -$1.12M | -$232,000.00 |
| Net Income to Parent Company | -$13.15M | -$29.53M | -$24.83M | -$60.51M | -$23.42M |
| Net Income to Common Stockholders | -$13.15M | -$29.53M | -$24.83M | -$60.51M | -$23.42M |
| Basic EPS | -$0.48 | -$1.05 | -$0.80 | -$1.97 | -$0.76 |
| Diluted EPS | -$0.48 | -$1.05 | -$0.80 | -$1.97 | -$0.76 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.08B | $1.09B | $1.16B | $1.21B | $1.21B |
| Total Current Assets | $383.74M | $454.77M | $479.04M | $550.49M | $550.49M |
| Cash and Cash Equivalents & Short-Term Investments | $292.74M | $257.03M | $276.30M | $336.08M | $336.08M |
| -Cash and Cash Equivalents | $86.79M | $26.31M | $23.40M | $50.19M | $50.19M |
| -Short Term Investments | $205.95M | $230.73M | $252.90M | $285.88M | $285.88M |
| Receivables | $69.17M | $70.53M | $75.74M | $91.61M | $91.61M |
| -Accounts Receivable | $62.49M | $64.94M | $69.28M | $84.76M | $84.76M |
| -Accrued Interest Receivable | $5.37M | $4.13M | $5.38M | $5.71M | $5.71M |
| -Other Receivables | $1.31M | $1.46M | $1.08M | $1.13M | $1.13M |
| Prepaid Assets | $9.62M | $115.55M | $114.95M | $112.20M | $112.20M |
| Inventory | $12.21M | $11.67M | $12.06M | $10.60M | $10.60M |
| Total Non-Current Assets | $695.19M | $634.45M | $677.33M | $663.04M | $663.04M |
| Net PPE | $110.74M | $113.07M | $116.34M | $112.55M | $112.55M |
| -Gross PPE | $176.67M | $177.36M | $177.65M | $170.49M | $170.49M |
| -Accumulated Depreciation | -$65.93M | -$64.30M | -$61.31M | -$57.95M | -$57.95M |
| Investments and Advances | $359.55M | $294.32M | $328.29M | $369.27M | $369.27M |
| -Available for Sale Securities | $359.55M | $294.32M | $328.29M | $369.27M | $369.27M |
| Goodwill and Other Intangible Assets | $200.66M | $203.12M | $207.72M | $158.36M | $158.36M |
| -Goodwill | $53.86M | $53.86M | $53.73M | $25.08M | $25.08M |
| -Other Intangible Assets | $146.80M | $149.26M | $153.99M | $133.28M | $133.28M |
| Other Non-Current Assets | $24.25M | $23.95M | $24.98M | $22.86M | $22.86M |
| Total Liabilities | $94.22M | $93.24M | $112.22M | $106.81M | $106.81M |
| Total Current Liabilities | $71.88M | $71.76M | $90.13M | $84.97M | $84.97M |
| Payables | $16.97M | $15.56M | $21.13M | $18.65M | $18.65M |
| -Accounts Payable | $16.97M | $15.56M | $21.13M | $18.65M | $18.65M |
| Current Accrued Expenses | $9.97M | $12.52M | $24.39M | $22.14M | $22.14M |
| Short-Term Debt and Capital Lease Obligation | $2.60M | $2.34M | $2.41M | $1.94M | $1.94M |
| -Current Debt | $482,000.00 | $482,000.00 | $482,000.00 | $476,000.00 | $476,000.00 |
| -Current Capital Lease Obligation | $2.11M | $1.86M | $1.93M | $1.46M | $1.46M |
| Current Deferred Liabilities | $32.35M | $32.21M | $33.63M | $31.78M | $31.78M |
| Total Non-Current Liabilities | $22.34M | $21.48M | $22.08M | $21.84M | $21.84M |
| Long Term Debt and Capital Lease Obligation | $7.68M | $7.09M | $7.48M | $5.74M | $5.74M |
| -Long Term Debt | $1.48M | $1.48M | $1.48M | $1.96M | $1.96M |
| -Long Term Capital Lease Obligation | $6.21M | $5.61M | $6.01M | $3.78M | $3.78M |
| Non-Current Deferred Liabilities | $6.96M | $6.89M | $6.98M | $6.94M | $6.94M |
| Other Non-Current Liabilities | $7.70M | $7.50M | $7.62M | $9.17M | $9.17M |
| Total Equity | $984.71M | $995.99M | $1.04B | $1.11B | $1.11B |
| Stockholders' Equity | $990.49M | $1.00B | $1.05B | $1.11B | $1.11B |
| Capital Stock | $4,000.00 | $4,000.00 | $4,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $4,000.00 | $4,000.00 | $4,000.00 | $3,000.00 | $3,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $531.56M | $524.10M | $540.14M | $574.52M | $574.52M |
| Retained Earnings | $462.45M | $475.60M | $505.13M | $529.95M | $529.95M |
| Gains/Losses Not Affecting Retained Earnings | -$3.53M | $1.92M | $4.54M | $7.51M | $7.51M |
| Minority Interests | -$5.78M | -$5.63M | -$5.66M | -$5.27M | -$5.27M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $109.23M | -$23.76M | $7.10M | -$101.64M | -$78.14M |
| Net cash flow from continuing operations | $109.23M | -$23.76M | $7.10M | -$101.64M | -$78.14M |
| Net Income from Continuing Operations | -$13.34M | -$29.72M | -$25.27M | -$61.63M | -$23.65M |
| Gain/Loss from Continuing Operations | -$5,000.00 | -$71,000.00 | -$9,000.00 | -$65,000.00 | -$41,000.00 |
| Depreciation & Depletion & Amortization | $6.82M | $7.68M | $6.00M | $24.12M | $6.11M |
| Deferred Tax | $264,000.00 | -$200,000.00 | -$921,000.00 | -$278,000.00 | $395,000.00 |
| Other Non-Cash Items | $585,000.00 | $469,000.00 | $353,000.00 | $1.79M | $563,000.00 |
| Change in Working Capital | $108.13M | -$15.63M | $16.76M | -$117.63M | -$71.71M |
| -Change in Receivables | $3.19M | $729,000.00 | $16.43M | -$23.25M | -$15.38M |
| -Change in Payables and Accrued Expense | $2.79M | -$18.11M | -$2.53M | $9.46M | $13.25M |
| -Change in Other Current Assets | -$3.05M | $2.28M | $2.79M | $798,000.00 | $1.82M |
| -Change in Other Current Liabilities | -$523,000.00 | -$505,000.00 | -$381,000.00 | -$1.63M | -$446,000.00 |
| -Change In Other Working Capital | $105.73M | -$28,000.00 | $449,000.00 | -$103.02M | -$70.96M |
| Net cash flow from investing | -$48.04M | $50.80M | $10.94M | $111.37M | $11.15M |
| Net Cash Flow from Continuing Investing Activities | -$48.04M | $50.80M | $10.94M | $111.37M | $11.15M |
| Net PPE Purchase and Sale | -$1.79M | -$3.86M | -$5.19M | -$22.57M | -$4.98M |
| Net Business Purchase and Sale | -$286,000.00 | $0.00 | -$55.57M | $3.78M | $0.00 |
| Net Investment Purchase and Sale | -$45.97M | $54.66M | $71.70M | $130.17M | $16.13M |
| Financing Cash Flow | -$724,000.00 | -$24.23M | -$44.83M | -$14.79M | -$534,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$724,000.00 | -$24.23M | -$44.83M | -$14.79M | -$534,000.00 |
| Net Issuance Payments Of Debt | -$93,000.00 | -$88,000.00 | -$564,000.00 | -$870,000.00 | -$88,000.00 |
| Net Common Stock Issuance | -$631,000.00 | -$24.14M | -$44.28M | -$13.92M | -$447,000.00 |
| Proceeds from Stock Option Exercised | $0.00 | $2,000.00 | $9,000.00 | $1,000.00 | $1,000.00 |
| Ending Cash Balance | $86.92M | $26.44M | $23.53M | $50.33M | $50.33M |
| Net Change in Cash | $60.47M | $2.82M | -$26.80M | -$5.06M | -$67.52M |
| Beginning Cash Balance | $26.44M | $23.53M | $50.33M | $55.28M | $117.78M |
| Effect of Exchange Rate Changes | $14,000.00 | $88,000.00 | $3,000.00 | $105,000.00 | $75,000.00 |
| Free Cash Flow | $107.44M | -$27.62M | $1.90M | -$124.21M | -$83.12M |
No comments yet — be the first to weigh in on FLGT.
Sign in to join the discussion.